Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Mar Drugs ; 16(11)2018 Nov 02.
Artigo em Inglês | MEDLINE | ID: mdl-30400250

RESUMO

The methods to obtain chitooligosaccharides are tightly related to the physicochemical properties of the end products. Knowledge of these physicochemical characteristics is crucial to describing the biological functions of chitooligosaccharides. Chitooligosaccharides were prepared either in a single-step enzymatic hydrolysis using chitosanase, or in a two-step chemical-enzymatic hydrolysis. The hydrolyzed products obtained in the single-step preparation were composed mainly of 42% fully deacetylated oligomers plus 54% monoacetylated oligomers, and they attenuated the inflammation in lipopolysaccharide-induced mice and in RAW264.7 macrophages. However, chitooligosaccharides from the two-step preparation were composed of 50% fully deacetylated oligomers plus 27% monoacetylated oligomers and, conversely, they promoted the inflammatory response in both in vivo and in vitro models. Similar proportions of monoacetylated and deacetylated oligomers is necessary for the mixtures of chitooligosaccharides to achieve anti-inflammatory effects, and it directly depends on the preparation method to which chitosan was submitted.


Assuntos
Anti-Inflamatórios/farmacologia , Quitina/análogos & derivados , Inflamação/tratamento farmacológico , Animais , Anti-Inflamatórios/química , Anti-Inflamatórios/metabolismo , Anti-Inflamatórios/uso terapêutico , Quitina/biossíntese , Quitina/química , Quitina/farmacologia , Quitina/uso terapêutico , Quitosana , Modelos Animais de Doenças , Glicosídeo Hidrolases/metabolismo , Humanos , Hidrólise , Inflamação/imunologia , Lipopolissacarídeos/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Estrutura Molecular , Oligossacarídeos , Células RAW 264.7 , Relação Estrutura-Atividade , Resultado do Tratamento
2.
Rev. lab. clín ; 5(3): 130-134, jul.-sept. 2012. tab
Artigo em Espanhol | IBECS | ID: ibc-105601

RESUMO

La hipercolesterolemia familiar (HF) es una de las enfermedades hereditarias más frecuentes, afectando a unas 10 millones de personas en todo el mundo. Se caracteriza por niveles elevados de c-LDL y por una elevada prevalencia de enfermedad cardiovascular prematura. La HF se origina por mutaciones en el gen que codifica el receptor de c-LDL. Presentamos el caso de un niño de 6 años que es remitido al laboratorio de Riesgo Cardiovascular (RCV) por sospecha de hipercolesterolemia familiar. Se le realiza una bioquímica general y un perfil de RCV, donde se observa un colesterol total y un c-LDL elevado, con el resto de los parámetros dentro de los rangos de normalidad. Se procede a la confirmación de la HF heterocigota mediante la determinación de la mutación del receptor de c-LDL (Lipochip(R)) mediante análisis genético (AU)


Familial hypercholesterolaemia (FH) is one of the most common hereditary diseases, affecting about 10 million people around the world. It is characterised by high levels of c-LDL, and a high prevalence of premature cardiovascular disease. It is caused by mutations in the gene that encodes the c-LDL receptor. We present the case of a 6 year-old child who was referred to the Cardiovascular Risk (CRV) Laboratory due to suspicion of familial hypercholesterolaemia. General biochemistry analysis and a CRV profile were performed, showing a high total cholesterol and c-LDL. As the rest of parameters were within the normal ranges, secondary causes of hypercholesterolaemia, such as hypothyroidism and diabetes, were ruled out. The presence of the FH heterozygote was confirmed by determining the mutation of the c-LDL receptor mutation by gene analysis (Lipochip (R)) (AU)


Assuntos
Humanos , Masculino , Criança , Protocolos Clínicos , Hiperlipoproteinemia Tipo II/diagnóstico , Hiperlipoproteinemia Tipo II/patologia , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/patologia , Doenças Cardiovasculares/prevenção & controle , Lipoproteínas/análise , Aterosclerose/diagnóstico , Aterosclerose/patologia , Fatores de Risco , Hiperlipoproteinemia Tipo II/genética , Hiperlipoproteinemia Tipo II/fisiopatologia , Bioquímica/métodos , Testes de Química Clínica/métodos , Testes de Química Clínica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...